Editorial: Heterogeneous catalysts for C1 molecules conversion.

Front Chem

State Key Laboratory of Clean and Efficient Coal Utilization, Taiyuan University of Technology, Taiyuan, China.

Published: January 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875155PMC
http://dx.doi.org/10.3389/fchem.2022.1121871DOI Listing

Publication Analysis

Top Keywords

editorial heterogeneous
4
heterogeneous catalysts
4
catalysts molecules
4
molecules conversion
4
editorial
1
catalysts
1
molecules
1
conversion
1

Similar Publications

Donor-specific antibodies (DSAs) targeting mismatched human leukocyte antigen (HLA) molecules are one of the principal threats to long-term graft survival in solid organ transplantation. However, many patients with long-term circulating DSAs do not manifest rejection responses, suggesting a degree of heterogeneity in their pathogenicity and related functional activity. Immunologic risk stratification of transplant recipients is complicated by challenges intrinsic to defining alloantibody responses that are potentially pathogenic versus those that are not.

View Article and Find Full Text PDF

Background: Interstitial lung diseases (ILDs) comprise a family of heterogeneous entities, primarily characterised by chronic scarring of the lung parenchyma. Among ILDs, idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pneumonitis, associated with progressive functional decline leading to respiratory failure, a high symptom burden, and mortality. Notably, the incidence of lung cancer (LC) in patients already affected by ILDs-mainly IPF-is significantly higher than in the general population.

View Article and Find Full Text PDF

Chronic Hydrocephalus and CSF Disturbances: A Heterogenous Group of Underestimated Diseases.

World Neurosurg

December 2024

Section of Neurosurgery, Department of Biomedicine, Neurosciences and Advanced Diagnostics (BiND), University of Palermo, Palermo, Italy. Electronic address:

View Article and Find Full Text PDF

No Association of Polycystic Ovary Syndrome with Pancreatic Cancer: A Mendelian Randomization Study.

Phenomics

October 2024

Institute of Women, Children and Reproductive Health, Shandong University, Jinan, 250012 Shandong China.

Unlabelled: Recently, there has been a debate regarding the association between polycystic ovary syndrome (PCOS) and pancreatic cancer (PC). In order to examine the causal relationship between PCOS and PC, we conducted a Mendelian randomization study, which utilized 12 single nucleotide polymorphisms (SNPs) identified from a genome-wide association study (GWAS) meta-analysis that included 10,074 PCOS cases and 103,164 controls of European ancestry as instrumental variables (IVs). The outcome data were obtained from the FinnGen database (including 605 cases and 218,187 controls).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!